Vuong Trieu - 16 Jun 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Issuer symbol: OTLC
Transactions as of: 16 Jun 2023
Net transactions value: +$2,600
Form type: 4
Filing time: 20 Jun 2023, 12:00:06 UTC
Previous filing: 16 Jun 2023
Next filing: 30 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$2,600	+100,000	+0.11%	$0.0260	91,544,217	16 Jun 2023	Direct
holding	OTLC	Common Stock						16,780,384	16 Jun 2023	By Autotelic, Inc.
holding	OTLC	Common Stock						6,872,529	16 Jun 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On June 16, 2023, Dr. Trieu purchased 100,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026.